Bioventus (BVS) Retained Earnings (2021 - 2026)

Bioventus (BVS) has 6 years of Retained Earnings data on file, last reported at -$331.8 million in Q1 2026.

• For the quarter ending Q1 2026, Retained Earnings rose 7.91% year-over-year to -$331.8 million; the trailing twelve-month figure through Mar 2026 stood at -$331.8 million (up 7.91% YoY), and the FY2025 full-year result was -$1.9 million, up 99.47% from the prior year.
• Retained Earnings for Q1 2026 stood at -$331.8 million, down from -$1.9 million in the prior quarter.
• Across five years, Retained Earnings topped out at $794000.0 in Q4 2023 and bottomed at -$360.3 million in Q1 2025.
• The 5-year median for Retained Earnings is -$25.1 million (2022), against an average of -$138.7 million.
• The widest annual swing landed in 2023, when Retained Earnings soared 213.77%; it then slumped 79060.29% in 2024.
• A 5-year view of Retained Earnings shows it stood at -$165.3 million in 2022, then surged by 100.48% to $794000.0 in 2023, then plunged by 45145.47% to -$357.7 million in 2024, then surged by 99.47% to -$1.9 million in 2025, then tumbled by 17364.0% to -$331.8 million in 2026.
• The last three Retained Earnings figures came in at -$331.8 million (Q1 2026), -$1.9 million (Q4 2025), and -$349.7 million (Q3 2025), per Business Quant data.

Peer Comparison